Autolus Therapeutics (AUTL) Inventory (2024 - 2025)
Autolus Therapeutics (AUTL) posted quarterly Inventory of $33.2 million for Q4 2025, up 702.54% year-on-year from $4.1 million in Q4 2024, and up 19.79% on a QoQ basis from $27.7 million in Q3 2025.
Autolus Therapeutics (AUTL) Inventory (2024 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Inventory for 2 consecutive years, with $33.2 million the latest figure, recorded in Q4 2025.
- Quarterly Inventory rose 702.54% year-over-year to $33.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $33.2 million (up 702.54% YoY) and the FY2025 annual result came in at $33.2 million, up 702.54% from the prior year.
- Inventory climbed to $33.2 million in Q4 2025 per AUTL's latest filing, from $27.7 million in the prior quarter.
- Over the last five years, Inventory for AUTL reached as high as $33.2 million in Q4 2025 and fell as low as $4.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | 33.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.21 Mn |
| Sep 30, 2025 | 27.72 Mn |
| Jun 30, 2025 | 23.94 Mn |
| Mar 31, 2025 | 14.65 Mn |
| Dec 31, 2024 | 4.14 Mn |